News & Resources
Recent Posts
Decode Health’s Key Takeaways from HLTH 2022
Last week’s fifth annual HLTH conference in Las Vegas was the biggest and boldest yet. The event was overflowing with interesting information and innovative ideas that push to define healthcare for the next decade. Many of the topics discussed tie directly to the work we do at Decode Health. Here are our team’s takeaways.
As Seen In
Podcasts
Publications
News
BD and Decode Health: Innovating to bring molecular tests to patients’ homes
We’re excited to announce the BD and Decode Health strategic partnership that will accelerate innovation and advance precision medicine. Together, we’re working to advance at home collections for molecular biomarkers like RNA using a simple finger stick. Our work could unlock groundbreaking innovations for biomarker discovery and routine screening across multiple disciplines from oncology to autoimmune diseases and beyond. At-home testing can significantly improve efficiency and enhance diversity in clinical trials, speeding the development of potentially life-saving treatments.
Decode Health Recognized as the 2022 Emerging Healthcare NEXT Awards Winner
Decode Health was recently honored for its commitment to advancing precision medicine and extraordinary promise for future endeavors with a 2022 Nashville Entrepreneur Center NEXT Award for healthcare innovation.
NIH Awards Decode Health $248K Grant to Detect and Distinguish Progressive Forms of Multiple Sclerosis
Decode Health today announced it received a $248,000 one year grant from the National Institutes of Health (NIH) to create new methods to distinguish relapsing-remitting and progressive forms of multiple sclerosis (MS).
Blog
Decode Health’s Key Takeaways from HLTH 2022
Last week’s fifth annual HLTH conference in Las Vegas was the biggest and boldest yet. The event was overflowing with interesting information and innovative ideas that push to define healthcare for the next decade. Many of the topics discussed tie directly to the work we do at Decode Health. Here are our team’s takeaways.
Biomarker Discovery to Improve Clinical Trials and Advance Precision Medicine
In the U.S., the cost of chronic diseases is more than $3.7T1 annually. Massive amounts of healthcare data are generated through wearable data, healthcare claims, electronic health records, and even complex genomic datasets. By 2025, the average individual will accumulate more than 4,900 daily digital device interactions2. Data alone, however, isn't the answer. The key is to find patterns within the data to proactively intervene and reduce the inefficiency within the $808 billion3 healthcare industry.
RNA Genomics: A Powerful Tool to Improve Population Health Management
Autoimmune diseases, such as multiple sclerosis (MS), ulcerative colitis, Crohn’s disease, and rheumatoid arthritis, are complex diseases that affect over four million people in the United States and cost the healthcare system over $90 billion annually. Autoimmune comorbidities present serious complications, increase hospitalization risks, and ultimately amplify the costs associated [read more...]
